There is currently one small IPO currently scheduled in the week ahead, although some small deals may join the calendar at the last minute.
New IPO filings could come online, as the SEC continues to work through a backlog of applications received during the government shutdown. A number of names on file may also launch in the week ahead, as the window narrows to list this year. Among the names that could target December listings are medical supplies provider Medline (MDLN), pan-Asian travel platform Klook (KLK), and construction company Cardinal Infrastructure (CDNL).
Israeli regenerative medicine company Regentis Biomaterials (RGNT) is scheduled to raise $11 million at a $62 million market cap. Its lead candidate is GelrinC, a cell-free, off-the-shelf hydrogel implant for painful injuries to articular knee cartilage. GelrinC was approved as a device in Europe in 2017, and the company is currently carrying out a pivotal trial for pre-marketing approval in the US.
| U.S. IPO Calendar | |||
|---|---|---|---|
| Issuer Business | Deal Size Market Cap | Price Range Shares Filed | Top Bookrunners |
| Regentis Biomaterials (RGNT) Herzliya, Israel | $11M $62M | $10 - $12 1,000,000 | ThinkEquity |
| Israeli regenerative medicine company developing orthopedic hydrogel implants. | |||
Sign up for a free trial of our premium platform, IPO Pro. To get our IPO calendar in your inbox, register here.
Street research is expected for three companies in the week ahead, and three lock-up periods will be expiring. For access to Street research and lock-up expiration dates, sign up for a free trial of IPO Pro.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 11/20/2025, the Renaissance IPO Index was down 2.2% year-to-date, while the S&P was up 12.4%. Renaissance Capital’s IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Kenvue (KVUE) and Arm Holdings (ARM). The Renaissance International IPO Index was up 31.7% year-to-date, while the ACWX was up 26.6%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Galderma and Horizon Robotics.
